...
首页> 外文期刊>Materials science & engineering, C. Materials for Biogical applications >Synthesis, characterization, DNA/HSA interactions and in vitro cytotoxic activities of two novel water-soluble copper(II) complexes with 1,3,5-triazine derivative ligand and amino acids
【24h】

Synthesis, characterization, DNA/HSA interactions and in vitro cytotoxic activities of two novel water-soluble copper(II) complexes with 1,3,5-triazine derivative ligand and amino acids

机译:两种新型水溶性铜(II)配合物的合成,表征,DNA / HSA相互作用及其体外细胞毒性活性与1,3,5-三嗪衍生物配体和氨基酸

获取原文
获取原文并翻译 | 示例
           

摘要

Two water-soluble copper(II) complexes of 6-(pyrazin-2-yl)-1,3,5-triazine-2,4-diamine (pzta) and amino acids, [Cu(pzta)(L-ArgH)(H2O)](ClO4)(2) (1) and [Cu(pzta)(L-Met)(H2O)]ClO4 center dot 3H(2)O (2) (L-ArgH: protonated L-Argininate; L-Met: L-Methioninate), were synthesized and characterized. The determined X-ray crystallographic structures of 1 and 2 exhibited distorted square-pyramidal coordination geometries. Their binding properties toward calf thymus DNA (CT-DNA) and human serum protein (HSA) were measured by spectroscopic (UV-Vis, fluorescence, circular dichroism (CD)), calorimetric (isothermal titration calorimetry (ITC)) and molecular docking technology. DNA binding experiments showed that the complexes bound to DNA through a groove binding mode, the positive Delta H and Delta S values indicated that the hydrophobic interaction was the main force in the binding between the complexes and DNA. Besides, the complexes caused the fluorescence quenching of HSA through a static quenching procedure, changed the secondary structure and microenvironment of the Trp-214 residue, and preferably bound to subdomain IIA of HSA driven by hydrophobic and hydrogen-bond interactions. These results were further verified by the molecular docking technology. Furthermore, the in vitro cytotoxicities of the complexes against three human carcinoma cell lines (A549, PC-3 and HeLa) were evaluated, which confirmed that the complexation improved the anticancer activity of the pzta ligand significantly.
机译:两个水溶性铜(II)络合物6-(吡嗪-2-基)-1,3,5-三嗪-2,4-二胺(PZTA)和氨基酸,[Cu(PZTA)(L-ARGH) (H 2 O)](CLO 4)(2)(1)和[Cu(PZTA)(L-MET)(H 2 O)] CLO4中心点3H(2)O(2)(L-ARGH:质子化L-杀菌; L - 用于合成和表征L-甲硫酸酯。确定的1和2的确定X射线晶体结构表现出扭曲的方形锥形配位几何形状。通过光谱(UV-Vis,荧光,圆形二色性(CD)),量热(等温滴定热量(ITC))和分子对接技术测量它们对小牛胸腺DNA(CT-DNA)和人血清蛋白(HSA)的结合性能。 DNA结合实验表明,通过沟槽结合模式使得与DNA结合的复合物,正ΔH和δ的值表明疏水相互作用是复合物和DNA之间结合的主力。此外,通过静态淬火程序使HSA的荧光猝灭导致TRP-214残基的二次结构和微环境改变,并且优选与疏水和氢键相互作用驱动的HSA的亚域IIA结合。通过分子对接技术进一步验证了这些结果。此外,评估复合物的体外细胞毒素(A549,PC-3和HeLa),证实络合显着改善了PZTA配体的抗癌活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号